Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80


Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.

Meyer S, Stevens A, Paredes R, Schneider M, Walker MJ, Williamson AJK, Gonzalez-Sanchez MB, Smetsers S, Dalal V, Teng HY, White DJ, Taylor S, Muter J, Pierce A, de Leonibus C, Rockx DAP, Rooimans MA, Spooncer E, Stauffer S, Biswas K, Godthelp B, Dorsman J, Clayton PE, Sharan SK, Whetton AD.

Cell Death Dis. 2017 Jun 15;8(6):e2875. doi: 10.1038/cddis.2017.264.


A specific PTPRC/CD45 phosphorylation event governed by stem cell chemokine CXCL12 regulates primitive hematopoietic cell motility.

Williamson AJ, Pierce A, Jaworska E, Zhou C, Aspinall-O'Dea M, Lancashire L, Unwin RD, Abraham SA, Walker MJ, Cadecco S, Spooncer E, Holyoake TL, Whetton AD.

Mol Cell Proteomics. 2013 Nov;12(11):3319-29. doi: 10.1074/mcp.M112.024604. Epub 2013 Sep 1.


Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation.

Pierce A, Williamson A, Jaworska E, Griffiths JR, Taylor S, Walker M, Aspinall-O'Dea M, Spooncer E, Unwin RD, Poolman T, Ray D, Whetton AD.

PLoS One. 2012;7(6):e38928. doi: 10.1371/journal.pone.0038928. Epub 2012 Jun 22. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/df82a4c0-2909-43a0-8a7f-5bd2ce9ca0bd. O'Dea, Mark Aspinall [corrected to Aspinall-O'Dea, Mark].


BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response.

Griaud F, Williamson AJ, Taylor S, Potier DN, Spooncer E, Pierce A, Whetton AD.

J Proteomics. 2012 Dec 21;77:14-26. doi: 10.1016/j.jprot.2012.06.003. Epub 2012 Jun 15.


Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia.

Bonadies N, Foster SD, Chan WI, Kvinlaug BT, Spensberger D, Dawson MA, Spooncer E, Whetton AD, Bannister AJ, Huntly BJ, Göttgens B.

PLoS One. 2011 Jan 28;6(1):e16330. doi: 10.1371/journal.pone.0016330.


THOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivo.

Mancini A, Niemann-Seyde SC, Pankow R, El Bounkari O, Klebba-Färber S, Koch A, Jaworska E, Spooncer E, Gruber AD, Whetton AD, Tamura T.

BMC Biol. 2010 Jan 5;8:1. doi: 10.1186/1741-7007-8-1.


Developmental fate determination and marker discovery in hematopoietic stem cell biology using proteomic fingerprinting.

Spooncer E, Brouard N, Nilsson SK, Williams B, Liu MC, Unwin RD, Blinco D, Jaworska E, Simmons PJ, Whetton AD.

Mol Cell Proteomics. 2008 Mar;7(3):573-81. Epub 2007 Dec 14.


Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases.

Pierce A, Unwin RD, Evans CA, Griffiths S, Carney L, Zhang L, Jaworska E, Lee CF, Blinco D, Okoniewski MJ, Miller CJ, Bitton DA, Spooncer E, Whetton AD.

Mol Cell Proteomics. 2008 May;7(5):853-63. Epub 2007 Oct 21.


The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells.

Burthem J, Rees-Unwin K, Mottram R, Adams J, Lucas GS, Spooncer E, Whetton AD.

Leukemia. 2007 Aug;21(8):1708-14. Epub 2007 Jun 7.


Differential effect of leukaemogenic tyrosine kinases on cell motility is governed by subcellular localisation.

Pierce A, Lu Y, Hamzah HG, Thompson S, Owen-Lynch PJ, Whetton AD, Spooncer E.

Br J Haematol. 2006 May;133(3):345-52.


Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells.

Unwin RD, Smith DL, Blinco D, Wilson CL, Miller CJ, Evans CA, Jaworska E, Baldwin SA, Barnes K, Pierce A, Spooncer E, Whetton AD.

Blood. 2006 Jun 15;107(12):4687-94. Epub 2006 Feb 28.


Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib.

Hamzah HG, Pierce A, Stewart WA, Peter Downes C, Gray A, Irvine A, Spooncer E, Whetton AD.

Leukemia. 2005 Oct;19(10):1851-3. No abstract available.


Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility.

Evans CA, Tonge R, Blinco D, Pierce A, Shaw J, Lu Y, Hamzah HG, Gray A, Downes CP, Gaskell SJ, Spooncer E, Whetton AD.

Blood. 2004 May 15;103(10):3751-9. Epub 2004 Feb 5.


Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1.

Whetton AD, Lu Y, Pierce A, Carney L, Spooncer E.

Blood. 2003 Oct 15;102(8):2798-802. Epub 2003 Jun 26.


BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD.

Oncogene. 2002 May 2;21(19):3068-75.


The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells.

Pierce A, Smith DL, Jakobsen LV, Whetton AD, Spooncer E.

Hematol J. 2001;2(4):257-64.


Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.

Pierce A, Spooncer E, Wooley S, Dive C, Francis JM, Miyan J, Owen-Lynch PJ, Dexter TM, Whetton AD.

Oncogene. 2000 Nov 16;19(48):5487-97.


Insertional mutagenesis as a route to identifying genes involved in self renewal of haemopoietic stem cells.

Just U, Boettiger D, Kan O, Dexter TM, Spooncer E.

Curr Top Microbiol Immunol. 2000;251:27-34.


Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.

Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD.

J Biol Chem. 2000 Dec 15;275(50):39137-45.

Supplemental Content

Loading ...
Support Center